Skip links

Latest

Make well informed decisions, quickly through industry leading process simulation, economic analysis software.

Get in touch
Continuous processing: Part 1

Continuous processing: Part 1

Over the next couple of blogs, we’d like to take a closer look at continuous processing, including the challenges associated with it, focusing on the cost drivers for perfusion versus fed batch, and the potential for continuous downstream processing. Continuous processing has increasingly been seen

Biopharm unveils BioSolve Process 5

Biopharm unveils BioSolve Process 5

Software demonstrates how shift from stainless steel to continuous processing technology potentially reduces CAPEX by over 75% and CoG below $20g/L Biopharm, the bioprocess analysis software developer, today announced the introduction of BioSolve Process 5, the latest version of the company’s flagship software tool. The

Mab Manufacturing Today & Tomorrow

Mab Manufacturing Today & Tomorrow

In conjunction with today’s launch of BioSolve Process 5, we have developed a whitepaper that demonstrates the significant savings that can be achieved by biopharma innovators in monoclonal antibody manufacture. The study used BioSolve Process to evaluate three different development scenarios: Current stainless steel technology

Biopharm presents at Modern Biopharmaceutical Manufacturing

Biopharm presents at Modern Biopharmaceutical Manufacturing

This week, Biopharm is delivering a presentation at PDA Europe’s Modern Biopharmaceutical Manufacturing conference in Lyon, France.  The presentation is entitled “Continuous Manufacturing, an Overview. Cost Drivers, Facility Impact, Quality Implications.” With a focus on the regulatory and quality aspects of biopharmaceutical production, this annual